Hong Kong · Delayed Price · Currency is HKD C-MER Medical Holdings Statistics
Total Valuation
HKG:3309 has a market cap or net worth of HKD 1.77 billion. The enterprise value is 1.92 billion.
| Market Cap | 1.77B |
| Enterprise Value | 1.92B |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:3309 has 1.19 billion shares outstanding. The number of shares has decreased by -2.00% in one year.
| Current Share Class | 1.19B |
| Shares Outstanding | 1.19B |
| Shares Change (YoY) | -2.00% |
| Shares Change (QoQ) | -1.13% |
| Owned by Insiders (%) | 2.14% |
| Owned by Institutions (%) | 2.35% |
| Float | 483.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.92 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 1.68 |
| P/FCF Ratio | 12.95 |
| P/OCF Ratio | 6.93 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.89, with an EV/FCF ratio of 14.01.
| EV / Earnings | -16.53 |
| EV / Sales | 0.99 |
| EV / EBITDA | 5.89 |
| EV / EBIT | 15.67 |
| EV / FCF | 14.01 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.51 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.29 |
| Debt / FCF | 3.09 |
| Interest Coverage | 5.06 |
Financial Efficiency
Return on equity (ROE) is -5.12% and return on invested capital (ROIC) is 6.46%.
| Return on Equity (ROE) | -5.12% |
| Return on Assets (ROA) | 2.81% |
| Return on Invested Capital (ROIC) | 6.46% |
| Return on Capital Employed (ROCE) | 5.31% |
| Weighted Average Cost of Capital (WACC) | 6.40% |
| Revenue Per Employee | 883,959 |
| Profits Per Employee | -52,984 |
| Employee Count | 2,189 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 25.39 |
Taxes
In the past 12 months, HKG:3309 has paid 31.58 million in taxes.
| Income Tax | 31.58M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.80% in the last 52 weeks. The beta is 0.47, so HKG:3309's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -22.80% |
| 50-Day Moving Average | 1.61 |
| 200-Day Moving Average | 1.78 |
| Relative Strength Index (RSI) | 42.44 |
| Average Volume (20 Days) | 515,956 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:3309 had revenue of HKD 1.93 billion and -115.98 million in losses. Loss per share was -0.10.
| Revenue | 1.93B |
| Gross Profit | 601.68M |
| Operating Income | 124.38M |
| Pretax Income | -69.22M |
| Net Income | -115.98M |
| EBITDA | 193.31M |
| EBIT | 124.38M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 435.71 million in cash and 423.12 million in debt, with a net cash position of 12.58 million or 0.01 per share.
| Cash & Cash Equivalents | 435.71M |
| Total Debt | 423.12M |
| Net Cash | 12.58M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 1.94B |
| Book Value Per Share | 1.48 |
| Working Capital | 215.07M |
Cash Flow
In the last 12 months, operating cash flow was 255.78 million and capital expenditures -118.96 million, giving a free cash flow of 136.82 million.
| Operating Cash Flow | 255.78M |
| Capital Expenditures | -118.96M |
| Free Cash Flow | 136.82M |
| FCF Per Share | 0.12 |
Margins
Gross margin is 31.09%, with operating and profit margins of 6.43% and -5.99%.
| Gross Margin | 31.09% |
| Operating Margin | 6.43% |
| Pretax Margin | -3.58% |
| Profit Margin | -5.99% |
| EBITDA Margin | 9.99% |
| EBIT Margin | 6.43% |
| FCF Margin | 7.07% |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 1.34%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 1.34% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.00% |
| Shareholder Yield | 3.38% |
| Earnings Yield | -6.55% |
| FCF Yield | 7.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:3309 has an Altman Z-Score of 2.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.75 |
| Piotroski F-Score | 3 |